$NWBO Headlines The Time Is Now For Northwest
Post# of 144503
Posted On: 10/30/2014 10:25:47 AM
$NWBO Headlines
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:15 a.m. Oct. 29, 2014 - InvestorPlace.com
Washington Post’s Pearlstein Didn't Intend to Disparage TheStreet’s Integrity 2:32 p.m. Oct. 28, 2014 - TheStreet.com
10 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 22, 2014 - InvestorPlace.com
10 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 15, 2014 - InvestorPlace.com
DXVAX-L Hospital Exemption Program Now Under Way In Germany 8:04 a.m. Oct. 14, 2014 - benzinga.com
Northwest Bio's Latest Financing Abuses Its Shareholders: Is The Charade Over? 2:26 p.m. Oct. 8, 2014 - Seeking Alpha
Update: Northwest Biotherapeutics Announces $11 Million Financing, Harms Shareholders Again 9:04 a.m. Oct. 8, 2014 - Seeking Alpha
Why Northwest Bio is Shunned by Savvy Healthcare Investors 7:43 a.m. Oct. 8, 2014 - TheStreet.com
8 Biotechnology Stocks to Buy Now 6:15 a.m. Oct. 8, 2014 - InvestorPlace.com
Northwest Biotherapeutics Misrepresents Clinical Trial Data 11:14 a.m. Oct. 1, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 1, 2014 - InvestorPlace.com
WP reporter writes a "hit piece" on (gasp!) Mr. Feuerstein 11:00 a.m. Sept. 30, 2014 - Seeking Alpha
TheStreet Seeks Retraction From Washington Post on Steven Pearlstein Column 10:14 a.m. Sept. 30, 2014 - TheStreet.com
The Case Of Northwest Biotherapeutics 1:35 p.m. Sept. 29, 2014 - Seeking Alpha
Northwest Biotherapeutics Valuation = $0 6:14 p.m. Sept. 26, 2014 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 5:45 a.m. Sept. 24, 2014 - InvestorPlace.com
Update: Northwest Biotherapeutics Stock In Turmoil, But Not For Long 1:49 p.m. Sept. 23, 2014 - Seeking Alpha
Northwest Bio's Almost-Toxic Debt Raise Responsible for Stock Slide 8:59 a.m. Sept. 22, 2014 - TheStreet.com
Northwest Biotherapeutics: U.K. May Grant Early Patient Access For DCVax-L Prior To Formal Approval 4:02 a.m. Sept. 18, 2014 - Seeking Alpha
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 2:41 p.m. Oct. 28, 2014 - PR Newswire - PRF
NORTHWEST BIOTHERAPEUTICS INC. ALERT -- Andrews & Springer LLC is Investigating Northwest Biotherapeutics Inc. for Potential Securities Fraud 8:01 a.m. Oct. 20, 2014 - GlobeNewswire
DCVAX®-L HOSPITAL EXEMPTION PROGRAM NOW UNDER WAY IN GERMANY 9:01 a.m. Oct. 14, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES $11.5 MILLION FINANCING 9:00 a.m. Oct. 7, 2014 - PR Newswire - PRF
NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 8:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
NW BIO CEO TO PRESENT AT SMi's 3rd ANNUAL CANCER VACCINES CONFERENCE IN LONDON 8:00 a.m. Sept. 15, 2014 - PR Newswire - PRF
NW BIO TO PRESENT UPDATES AT RODMAN RENSHAW 16TH ANNUAL GLOBAL INVESTMENT CONFERENCE 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2:44 p.m. Aug. 19, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES 11:47 a.m. Aug. 14, 2014 - PR Newswire - PRF
NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS 9:26 a.m. Aug. 13, 2014 - PR Newswire - PRF
NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:46 p.m. July 30, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Northwest Biotherapeutics, Inc. Stockholders 7:13 p.m. July 23, 2014 - BusinessWire - BZX
NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 4:55 p.m. July 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 6:23 p.m. July 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northwest Biotherapeutics, Inc. - NWBO 6:31 p.m. July 7, 2014 - PR Newswire - PRF
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Northwest Biotherapeutics, Inc. (NWBO) To Contact The Firm 1:17 p.m. July 4, 2014 - PR Newswire - PRF
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:15 a.m. Oct. 29, 2014 - InvestorPlace.com
Washington Post’s Pearlstein Didn't Intend to Disparage TheStreet’s Integrity 2:32 p.m. Oct. 28, 2014 - TheStreet.com
10 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 22, 2014 - InvestorPlace.com
10 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 15, 2014 - InvestorPlace.com
DXVAX-L Hospital Exemption Program Now Under Way In Germany 8:04 a.m. Oct. 14, 2014 - benzinga.com
Northwest Bio's Latest Financing Abuses Its Shareholders: Is The Charade Over? 2:26 p.m. Oct. 8, 2014 - Seeking Alpha
Update: Northwest Biotherapeutics Announces $11 Million Financing, Harms Shareholders Again 9:04 a.m. Oct. 8, 2014 - Seeking Alpha
Why Northwest Bio is Shunned by Savvy Healthcare Investors 7:43 a.m. Oct. 8, 2014 - TheStreet.com
8 Biotechnology Stocks to Buy Now 6:15 a.m. Oct. 8, 2014 - InvestorPlace.com
Northwest Biotherapeutics Misrepresents Clinical Trial Data 11:14 a.m. Oct. 1, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:00 a.m. Oct. 1, 2014 - InvestorPlace.com
WP reporter writes a "hit piece" on (gasp!) Mr. Feuerstein 11:00 a.m. Sept. 30, 2014 - Seeking Alpha
TheStreet Seeks Retraction From Washington Post on Steven Pearlstein Column 10:14 a.m. Sept. 30, 2014 - TheStreet.com
The Case Of Northwest Biotherapeutics 1:35 p.m. Sept. 29, 2014 - Seeking Alpha
Northwest Biotherapeutics Valuation = $0 6:14 p.m. Sept. 26, 2014 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 5:45 a.m. Sept. 24, 2014 - InvestorPlace.com
Update: Northwest Biotherapeutics Stock In Turmoil, But Not For Long 1:49 p.m. Sept. 23, 2014 - Seeking Alpha
Northwest Bio's Almost-Toxic Debt Raise Responsible for Stock Slide 8:59 a.m. Sept. 22, 2014 - TheStreet.com
Northwest Biotherapeutics: U.K. May Grant Early Patient Access For DCVax-L Prior To Formal Approval 4:02 a.m. Sept. 18, 2014 - Seeking Alpha
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 2:41 p.m. Oct. 28, 2014 - PR Newswire - PRF
NORTHWEST BIOTHERAPEUTICS INC. ALERT -- Andrews & Springer LLC is Investigating Northwest Biotherapeutics Inc. for Potential Securities Fraud 8:01 a.m. Oct. 20, 2014 - GlobeNewswire
DCVAX®-L HOSPITAL EXEMPTION PROGRAM NOW UNDER WAY IN GERMANY 9:01 a.m. Oct. 14, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES $11.5 MILLION FINANCING 9:00 a.m. Oct. 7, 2014 - PR Newswire - PRF
NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 8:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
NW BIO CEO TO PRESENT AT SMi's 3rd ANNUAL CANCER VACCINES CONFERENCE IN LONDON 8:00 a.m. Sept. 15, 2014 - PR Newswire - PRF
NW BIO TO PRESENT UPDATES AT RODMAN RENSHAW 16TH ANNUAL GLOBAL INVESTMENT CONFERENCE 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2:44 p.m. Aug. 19, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES 11:47 a.m. Aug. 14, 2014 - PR Newswire - PRF
NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS 9:26 a.m. Aug. 13, 2014 - PR Newswire - PRF
NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:46 p.m. July 30, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Northwest Biotherapeutics, Inc. Stockholders 7:13 p.m. July 23, 2014 - BusinessWire - BZX
NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 4:55 p.m. July 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 6:23 p.m. July 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northwest Biotherapeutics, Inc. - NWBO 6:31 p.m. July 7, 2014 - PR Newswire - PRF
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Northwest Biotherapeutics, Inc. (NWBO) To Contact The Firm 1:17 p.m. July 4, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼